Copenhagen:ZEALPublished
Zealand Pharma announces initiation of the Phase 2 ZYNERGY trial of petrelintide co-administered with enicepatide in people with obesity or overweight
Press release – No. 25 / 2026 Zealand Pharma announces initiation of the Phase 2 ZYNERGY trial of petrelintide co-administered with enicepatide in people with obesity or overweight The Phase 2 ZYNERGY trial investigates the efficacy and safety of petrelintide co-administered…